Cystathionine beta synthase deficiency and brain edema associated with methionine excess under betaine supplementation: Four new cases and a review of the evidence.
CBS deficiency
adverse drug effect
betaine
brain edema
encephalopathy
homocystinuria
Journal
JIMD reports
ISSN: 2192-8304
Titre abrégé: JIMD Rep
Pays: United States
ID NLM: 101568557
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
received:
25
09
2019
revised:
19
11
2019
accepted:
04
12
2019
entrez:
11
3
2020
pubmed:
11
3
2020
medline:
11
3
2020
Statut:
epublish
Résumé
CBS deficient individuals undergoing betaine supplementation without sufficient dietary methionine restriction can develop severe hypermethioninemia and brain edema. Brain edema has also been observed in individuals with severe hypermethioninemia without concomitant betaine supplementation. We systematically evaluated reports from 11 published and 4 unpublished patients with CBS deficiency and from additional four cases of encephalopathy in association with elevated methionine. We conclude that, while betaine supplementation does greatly exacerbate methionine accumulation, the primary agent causing brain edema is methionine rather than betaine. Clinical signs of increased intracranial pressure have not been seen in patients with plasma methionine levels below 559 μmol/L but occurred in one patient whose levels did not knowingly exceed 972 μmol/L at the time of manifestation. While levels below 500 μmol/L can be deemed safe it appears that brain edema can develop with plasma methionine levels close to 1000 μmol/L. Patients with CBS deficiency on betaine supplementation need to be regularly monitored for concordance with their dietary plan and for plasma methionine concentrations. Recurrent methionine levels above 500 μmol/L should alert clinicians to check for clinical signs and symptoms of brain edema and review dietary methionine intake. Levels approaching 1000 μmol/L do increase the risk of complications and levels exceeding 1000 μmol/L, despite best dietetic efforts, should be acutely addressed by reducing the prescribed betaine dose.
Identifiants
pubmed: 32154053
doi: 10.1002/jmd2.12092
pii: JMD212092
pmc: PMC7052692
doi:
Types de publication
Case Reports
Langues
eng
Pagination
3-10Informations de copyright
© 2020 The Authors. Journal of Inherited Metabolic Disease published by John Wiley & Sons Ltd on behalf of SSIEM.
Déclaration de conflit d'intérêts
B Schwahn reports personal fees from Orphan Europe, outside the submitted work. Other authors do not report any conflict of interest. T.S., H.S., P.V., A.D., J.F., H.J.B., J.F.B., B.A.B., J.J.B., and A.F. declare they have no conflict of interest.
Références
Metabolism. 1993 Nov;42(11):1448-60
pubmed: 7694037
Orphanet J Rare Dis. 2019 Mar 14;14(1):66
pubmed: 30871635
AJNR Am J Neuroradiol. 2004 Nov-Dec;25(10):1843-5
pubmed: 15569761
FASEB J. 2003 Mar;17(3):512-4
pubmed: 12551843
Eur J Clin Nutr. 1996 Feb;50 Suppl 1:S119-47; discussion S147-50
pubmed: 8641256
Front Physiol. 2014 Apr 24;5:159
pubmed: 24795654
JIMD Rep. 2019;44:115-119
pubmed: 30187370
J Nutr. 2006 Jun;136(6 Suppl):1722S-1725S
pubmed: 16702346
Mol Genet Metab. 2003 May;79(1):6-16
pubmed: 12765841
AJNR Am J Neuroradiol. 2005 Nov-Dec;26(10):2705-6
pubmed: 16286426
Am J Med Genet. 2002 Feb 15;108(1):57-63
pubmed: 11857551
Arch Fr Pediatr. 1977 May;34(5):416-23
pubmed: 889406
Mol Genet Metab. 2013 Dec;110(4):454-9
pubmed: 24206934
Arterioscler Thromb Vasc Biol. 2002 Jun 1;22(6):1046-50
pubmed: 12067919
J Radiol Case Rep. 2018 Jan 31;12(1):1-8
pubmed: 29875981
Q J Med. 1966 Jul;35(139):325-46
pubmed: 5956442
J Neurochem. 1987 Nov;49(5):1651-8
pubmed: 3668544
Arch Dis Child. 1974 Jul;49(7):553-9
pubmed: 4851308
Am J Med Genet C Semin Med Genet. 2011 Feb 15;157C(1):3-32
pubmed: 21308989
Biochem J. 2004 Sep 15;382(Pt 3):831-40
pubmed: 15217352
J Pediatr. 1981 Sep;99(3):467-72
pubmed: 7264811
Eur J Pediatr. 1984 Jun;142(2):147-50
pubmed: 6381059
Orphanet J Rare Dis. 2015 Aug 20;10:99
pubmed: 26289392
Amino Acids. 2016 Nov;48(11):2479-2489
pubmed: 27465642
Br J Clin Pharmacol. 2003 Jan;55(1):6-13
pubmed: 12534635
JIMD Rep. 2020 Jan 08;52(1):3-10
pubmed: 32154053
J Pediatr. 2004 Apr;144(4):545-8
pubmed: 15069409
J Child Neurol. 2014 Jan;29(1):88-92
pubmed: 23155204
Clin Nutr. 2002 Apr;21(2):151-6
pubmed: 12056788
J Inherit Metab Dis. 2017 Jan;40(1):49-74
pubmed: 27778219
J Magn Reson Imaging. 2006 Mar;23(3):404-7
pubmed: 16463305
Neurosci Lett. 1994 Jul 4;175(1-2):103-6
pubmed: 7970187
Tohoku J Exp Med. 2015;237(4):323-7
pubmed: 26639091
Am J Clin Nutr. 2008 Mar;87(3):577-85
pubmed: 18326594
J Inherit Metab Dis. 1998 Feb;21(1):84-5
pubmed: 9501279
J Inherit Metab Dis. 2008 Dec;31 Suppl 3:477-81
pubmed: 18210212